Two Republican lawmakers feel 'obliged' to warn drugmakers that Democrat colleague Cummings is purportedly out to deflate their stock prices

The prolific chairman of the Committee on Oversight and Reform Elijah Cummings kicked off an investigation into “skyrocketing” drug prices in the United States — a contentious issue that has sparked bipartisan furor — when he sent inquiries to a dozen major drugmakers seeking information on pricing practices this January. But it looks like two of his Republican colleagues are not impressed with the probe, insinuating that the Democrat senator is collecting “sensitive information” to bring down pharmaceutical stock prices.